discussed
in forward-looking statements. Readers are urged to carefully review and
consider the various disclosures made by SpectraScience in this news
release, its most recent Form 10-K and in SpectraScience's other reports
filed with the Securities and Exchange Commission ("SEC") that attempt to
advise interested parties of the risks and factors that may affect
SpectraScience's business. These forward- looking statements are qualified
in their entirety by the cautions and risk factors filed by SpectraScience
in its annual report on Form 10-K and other documents.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that
designs, develops, manufactures and markets spectrophotometry systems
capable of determining whether tissue is normal, pre-cancerous or cancerous
without physically removing tissue from the body. The WavSTAT Optical
Biopsy System uses light to optically scan tissue and provide the physician
with an immediate analysis. With FDA approval for sale in the U.S. and the
CE Mark for the European Union, the WavSTAT System is the first
commercially available product that incorporates this innovative technology
for clinical use. The Company's LUMA imaging technology has received FDA
approval for an optical non-invasive system that is proven to more
effectively detect cervical cancer precursors than conventional methods
available in the market today.
Contact:
SpectraScience, Inc.
Jim Hitchin, Chief Executive Officer
(858) 847-0200 x201
Hayden Communications
Investor Relations
Todd Pitcher
(858) 518-1387
'/>"/>SOURCE SpectraScience, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
SpectraScience Strengthens Leadership Team With Four Key Hires2.
Jim Dorst Joins SpectraScience as CFO3.
SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors4.
Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition5.
GeneGo Is Awarded NCI Grant for Development of Systems Biology Database and Tools for Nutrition in Cancer in Collaboration with the FDA6.
PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program7.
Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program8.
eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections9.
Dr. Yong Shi awarded NSF grant10.
Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million11.
BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications